<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34946792</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>23</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Individual Oligogenic Background in p.D91A-<i>SOD1</i> Amyotrophic Lateral Sclerosis Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1843</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes12121843</ELocationID><Abstract><AbstractText>The p.D91A is one of the most common ALS-causing <i>SOD1</i> mutations and is known to be either recessive or dominant. The homozygous phenotype is characterized by prolonged survival and slow progression of disease, whereas the affected heterozygous phenotypes can vary. To date, no genetic protective factors located close to <i>SOD1</i> have been associated with the mild progressive homozygous phenotype. Using Next Generation Sequencing (NGS), we characterized a small cohort of sporadic and familial p.D91A-<i>SOD1</i> heterozygous (<i>n</i> = 2) or homozygous (<i>n</i> = 5) ALS patients, to reveal any additional contributing variant in 39 ALS-related genes. We detected unique sets of non-synonymous variants, four of which were of uncertain significance and several in untranslated regions of ALS-related genes. Our results supported an individual oligogenic background underlying both sporadic and familial p.D91A cases irrespective of their p.D91A mutant alleles. We suggest that a comprehensive genomic view of p.D91A-<i>SOD1</i> ALS patients may be useful in identifying emerging variants and improving disease diagnosis as well as guiding precision medicine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gentile</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0180-3481</Identifier><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, Department of Biomedical Sciences, National Research Council (CNR), 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrone</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Genetics Laboratory, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, Department of Biomedical Sciences, National Research Council (CNR), 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simone</LastName><ForeName>Isabella Laura</ForeName><Initials>IL</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", 70121 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>And&#xf2;</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Genetics Laboratory, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Sanitario, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallaro</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7590-1792</Identifier><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, Department of Biomedical Sciences, National Research Council (CNR), 95126 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conforti</LastName><ForeName>Francesca Luisa</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0001-8364-1783</Identifier><AffiliationInfo><Affiliation>Medical Genetics Laboratory, Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NGS targeted-gene panel</Keyword><Keyword MajorTopicYN="N">individual oligogenic background</Keyword><Keyword MajorTopicYN="N">p.D91A-SOD1</Keyword><Keyword MajorTopicYN="N">zygosity</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34946792</ArticleId><ArticleId IdType="pmc">PMC8701978</ArticleId><ArticleId IdType="doi">10.3390/genes12121843</ArticleId><ArticleId IdType="pii">genes12121843</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S., Noyce A.J., Hemani G., Nicolas A., Calvo A., Mora G., Arosio A., Barberis M., Bartolomei I., Battistini S., et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann. Neurol. 2019;85:470&#x2013;481. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Felbecker A., Camu W., Valdmanis P.N., Sperfeld A.D., Waibel S., Steinbach P., Rouleau G.A., Ludolph A.C., Andersen P.M. Four familial ALS pedigrees discordant for two SOD1 mutations: Are all SOD1 mutations pathogenic? J. Neurol. Neurosurg. Psychiatry. 2010;81:572&#x2013;577. doi: 10.1136/jnnp.2009.192310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.192310</ArticleId><ArticleId IdType="pubmed">20460594</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrugia Wismayer M., Farrugia Wismayer A., Pace A., Vassallo N., Cauchi R.J. SOD1 D91A variant in the southernmost tip of Europe: A heterozygous ALS patient resident on the island of Gozo. Eur. J. Hum. Genet. 2021;27:27&#x2013;30. doi: 10.1038/s41431-021-00975-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-021-00975-x</ArticleId><ArticleId IdType="pubmed">34616013</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehm H.L., Berg J.S., Brooks L.D., Bustamante C.D., Evans J.P., Landrum M.J., Ledbetter D.H., Maglott D.R., Martin C.L., Nussbaum R.L., et al. ClinGen &#x2014; The Clinical Genome Resource. N. Engl. J. Med. 2015;372:2235&#x2013;2242. doi: 10.1056/NEJMsr1406261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1406261</ArticleId><ArticleId IdType="pmc">PMC4474187</ArticleId><ArticleId IdType="pubmed">26014595</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Nilsson P., Ala-Hurula V., Ker&#xe4;nen M.L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet. 1995;10:61&#x2013;66. doi: 10.1038/ng0595-61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0595-61</ArticleId><ArticleId IdType="pubmed">7647793</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Forsgren L., Binzer M., Nilsson P., Ala-Hurula V., Ker&#xe4;nen M.L., Bergmark L., Saarinen A., Haltia T., Tarvainen I., et al. Autosomal recessive adult-onset amyohophic lateral sclerosis associated with homozygosity for Asp90A1a CuZn-superoxide dismutase mutation A clinical and genealogical study of 36 patients. Brain. 1996;119:1153&#x2013;1172. doi: 10.1093/brain/119.4.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Aguirre T., Van Den Bosch L., Tilkin P., Cassiman J.J., Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology. 1996;47:1336&#x2013;1339. doi: 10.1212/WNL.47.5.1336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.5.1336</ArticleId><ArticleId IdType="pubmed">8909456</ArticleId></ArticleIdList></Reference><Reference><Citation>Skvortsova V.I., Limborska S.A., Slominsky P.A., Levitskaya N.I., Levitsky G.N., Shadrina M.I., Kondratyeva E.A. Sporadic ALS associated with the D90A CU,ZN superoxide dismutase mutation in Russia. Eur. J. Neurol. 2001;8:167&#x2013;172. doi: 10.1046/j.1468-1331.2001.00186.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.2001.00186.x</ArticleId><ArticleId IdType="pubmed">11284995</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini F., Battistini S., Mancuso M., Greco G., Ricci C., Volpi N., Del Corona A., Piazza S., Siciliano G. D90A-SOD1 mutation in ALS: The first report of heterozygous Italian patients and unusual findings. Amyotroph. Lateral Scler. 2010;11:216&#x2013;219. doi: 10.3109/17482960902721642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902721642</ArticleId><ArticleId IdType="pubmed">20184519</ArticleId></ArticleIdList></Reference><Reference><Citation>Parton M.J., Broom W., Andersen P.M., Al-Chalabi A., Nigel Leigh P., Powell J.F., Shaw C.E. D90A-SOD1 mediated amyotrophic lateral sclerosis: A single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum. Mutat. 2002;20:473. doi: 10.1002/humu.9081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.9081</ArticleId><ArticleId IdType="pubmed">12442272</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisa Conforti F., Sprovieri T., Mazzei R., Patitucci A., Ungaro C., Zoccolella S., Magariello A., Bella V.L., Tessitore A., Tedeschi G., et al. Further evidence that D90A-SOD1 mutation is recessively inherited in ALS patients in Italy. Amyotroph. Lateral Scler. 2009;10:58&#x2013;60. doi: 10.1080/17482960802163853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802163853</ArticleId><ArticleId IdType="pubmed">18608106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard E., Pegat A., Svahn J., Bouhour F., Leblanc P., Millecamps S., Thobois S., Guissart C., Lumbroso S., Mouzat K. Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study. Int. J. Mol. Sci. 2020;21:6807. doi: 10.3390/ijms21186807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186807</ArticleId><ArticleId IdType="pmc">PMC7554847</ArticleId><ArticleId IdType="pubmed">32948071</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoris J., Moulard B., Briolotti V., Hayer M., Durieux A., Clavelou P., Malafosse A., Rouleau G.A., Camu W. Coexistence of dominant and recessive familial amyotrophic lateral sclerosis with the D90A Cu,Zn superoxide dismutase mutation within the same country. Eur. J. Neurol. 2000;7:207&#x2013;211. doi: 10.1046/j.1468-1331.2000.00028.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.2000.00028.x</ArticleId><ArticleId IdType="pubmed">10809943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry J.L., Ryan &#xc9;.B., Esengul Y.T., Siddique N., Siddique T. Intricacies of aetiology in intrafamilial degenerative disease. Brain Commun. 2020;2 doi: 10.1093/braincomms/fcaa120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa120</ArticleId><ArticleId IdType="pmc">PMC7585693</ArticleId><ArticleId IdType="pubmed">33134917</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistini S., Giannini F., Greco G., Bibb&#xf2; G., Ferrera L., Marini V., Causarano R., Casula M., Lando G., Patrosso M.C., et al. SOD1 mutations in amyotrophic lateral sclerosis. J. Neurol. 2005;252:782&#x2013;788. doi: 10.1007/s00415-005-0742-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0742-y</ArticleId><ArticleId IdType="pubmed">15789135</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M.A., Hennekam E.A.M., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 2006;6:37&#x2013;46. doi: 10.1007/s11910-996-0008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-996-0008-9</ArticleId><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand C.K., Mayeux-Portas V., Khoris J., Briolotti V., Clavelou P., Camu W., Rouleau G.A. Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann. Neurol. 2001;49:267&#x2013;271. doi: 10.1002/1531-8249(20010201)49:2&lt;267::AID-ANA51&gt;3.0.CO;2-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(20010201)49:2&lt;267::AID-ANA51&gt;3.0.CO;2-D</ArticleId><ArticleId IdType="pubmed">11220750</ArticleId></ArticleIdList></Reference><Reference><Citation>Parton M.J., Andersen P.M., Broom W.J., Shaw C.E. Compound heterozygosity and variable penetrance inSOD1 amyotrophic lateral sclerosis pedigrees. Ann. Neurol. 2001;50:553. doi: 10.1002/ana.1151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.1151</ArticleId><ArticleId IdType="pubmed">11601511</ArticleId></ArticleIdList></Reference><Reference><Citation>Luigetti M., Conte A., Madia F., Marangi G., Zollino M., Mancuso I., Dileone M., Del Grande A., Di Lazzaro V., Tonali P.A., et al. Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis. Neurol. Sci. 2009;30:517&#x2013;520. doi: 10.1007/s10072-009-0125-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-009-0125-8</ArticleId><ArticleId IdType="pubmed">19685200</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuuluvainen L., Kaivola K., M&#xf6;nk&#xe4;re S., Laaksovirta H., Jokela M., Udd B., Valori M., Pasanen P., Paetau A., Traynor B.J., et al. Oligogenic basis of sporadic ALS The example of SOD1 p.Ala90Val mutation. Neurol Genet. 2019;5:335. doi: 10.1212/NXG.0000000000000335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000335</ArticleId><ArticleId IdType="pmc">PMC6481226</ArticleId><ArticleId IdType="pubmed">31086828</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E., Turner M.R., Ansorge O., Talbot K. Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology. Neurology. 2020;95:595&#x2013;596. doi: 10.1212/WNL.0000000000010587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010587</ArticleId><ArticleId IdType="pubmed">32769137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto Y., Ihara M., Urushitani M., Yamashita H., Kondo T., Tanigaki A., Oono M., Kawamata J., Ikemoto A., Kawamoto Y., et al. An autopsy case of SOD1-related ALS with TDP-43 positive inclusions. Neurology. 2011;77:1993&#x2013;1995. doi: 10.1212/WNL.0b013e31823a0cfc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31823a0cfc</ArticleId><ArticleId IdType="pubmed">22094482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Ciura S., Rouleau G.A., Kabashi E. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) Trends Genet. 2015;31:263&#x2013;273. doi: 10.1016/j.tig.2015.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2015.03.005</ArticleId><ArticleId IdType="pubmed">25869998</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., van der Zee J. ALS Genes in the Genomic Era and their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Shatunov A., Sproviero W., Jones A.R., Shoai M., Hughes D., Al Khleifat A., Malaspina A., Morrison K.E., Shaw P.J., et al. A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK. Brain. 2017;140:1611&#x2013;1618. doi: 10.1093/brain/awx082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx082</ArticleId><ArticleId IdType="pmc">PMC5445258</ArticleId><ArticleId IdType="pubmed">28430856</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom W.J., Johnson D.V., Garber M., Andersen P.M., Lennon N., Landers J., Nusbaum C., Russ C., Brown R.H. DNA sequence analysis of the conserved region around the SOD1 gene locus in recessively inherited ALS. Neurosci. Lett. 2009;463:64&#x2013;69. doi: 10.1016/j.neulet.2009.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.07.010</ArticleId><ArticleId IdType="pubmed">19596401</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungaro C., Sprovieri T., Morello G., Perrone B., Spampinato A.G., Simone I.L., Trojsi F., Monsurr&#xf2; M.R., Spataro R., La Bella V., et al. Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: A two-decade analysis. Neurobiol. Aging. 2021;99:99.e7&#x2013;99.e14. doi: 10.1016/j.neurobiolaging.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.08.017</ArticleId><ArticleId IdType="pubmed">32951934</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Van Den Berg L.H., Veldink J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungaro C., Citrigno L., Trojsi F., Sprovieri T., Gentile G., Muglia M., Monsurr&#xf2; M.R., Tedeschi G., Cavallaro S., Conforti F.L. ALS and CHARGE syndrome: A clinical and genetic study. Acta Neurol. Belg. 2018;4:629&#x2013;635. doi: 10.1007/s13760-018-1029-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-018-1029-2</ArticleId><ArticleId IdType="pmc">PMC6244742</ArticleId><ArticleId IdType="pubmed">30317490</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S., Coldren C., Karunamurthy A., Kip N.S., Klee E.W., Lincoln S.E., Leon A., Pullambhatla M., Temple-Smolkin R.L., Voelkerding K.V., et al. Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines. J. Mol. Diagnostics. 2018;20:4&#x2013;27. doi: 10.1016/j.jmoldx.2017.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2017.11.003</ArticleId><ArticleId IdType="pubmed">29154853</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek R.A.A., van Rheenen W., Pulit S.L., Kenna K.P., van den Berg L.H., Veldink J.H. The project MinE databrowser: Bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph. Lateral Scler. Front. Degener. 2019;20:432&#x2013;440. doi: 10.1080/21678421.2019.1606244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1606244</ArticleId><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiati E., Borsani G., Giacopuzzi E. Amplicon-based semiconductor sequencing of human exomes: Performance evaluation and optimization strategies. Hum. Genet. 2016;135:499&#x2013;511. doi: 10.1007/s00439-016-1656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1656-8</ArticleId><ArticleId IdType="pmc">PMC4835520</ArticleId><ArticleId IdType="pubmed">27003585</ArticleId></ArticleIdList></Reference><Reference><Citation>Summa S.D., Malerba G., Mori A., Mijatovic V., Pinto R., Tommasi S. Quality measures to improve variant calling of Ion Torrent data; Proceedings of the NETTAB &amp; IB; Bari, Italy. 14&#x2013;16 October 2015;  [(accessed on 22 October 2021)].  Available online:  http://www.igst.it/nettab/2015/files/2017/02/NETTAB2015_DeSumma.pdf.</Citation></Reference><Reference><Citation>Kopanos C., Tsiolkas V., Kouris A., Chapple C.E., Albarca Aguilera M., Meyer R., Massouras A. VarSome: The human genomic variant search engine. Bioinformatics. 2019;35:1978&#x2013;1980. doi: 10.1093/bioinformatics/bty897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty897</ArticleId><ArticleId IdType="pmc">PMC6546127</ArticleId><ArticleId IdType="pubmed">30376034</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum M.J., Lee J.M., Benson M., Brown G.R., Chao C., Chitipiralla S., Gu B., Hart J., Hoffman D., Jang W., et al. ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062&#x2013;D1067. doi: 10.1093/nar/gkx1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1153</ArticleId><ArticleId IdType="pmc">PMC5753237</ArticleId><ArticleId IdType="pubmed">29165669</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzsch P., Witten D., Cooper G.M., Shendure J., Kircher M. CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886&#x2013;D894. doi: 10.1093/nar/gky1016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1016</ArticleId><ArticleId IdType="pmc">PMC6323892</ArticleId><ArticleId IdType="pubmed">30371827</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguet F., Barbeira A.N., Bonazzola R., Jo B., Kasela S., Liang Y., Parsana P., Aguet F., Battle A., Brown A., et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318&#x2013;1330. doi: 10.1126/science.aaz1776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz1776</ArticleId><ArticleId IdType="pmc">PMC7737656</ArticleId><ArticleId IdType="pubmed">32913098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hysi P.G., Choquet H., Khawaja A.P., Wojciechowski R., Tedja M.S., Yin J., Simcoe M.J., Patasova K., Mahroo O.A., Thai K.K., et al. Meta-analysis of 542,934 subjects of European ancestry identifies new genes and mechanisms predisposing to refractive error and myopia. Nat. Genet. 2020;52:401&#x2013;407. doi: 10.1038/s41588-020-0599-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0599-0</ArticleId><ArticleId IdType="pmc">PMC7145443</ArticleId><ArticleId IdType="pubmed">32231278</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuckovic D., Bao E.L., Akbari P., Lareau C.A., Mousas A., Jiang T., Chen M.-H., Raffield L.M., Tardaguila M., Huffman J.E., et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell. 2020;182:1214&#x2013;1231.e11. doi: 10.1016/j.cell.2020.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.008</ArticleId><ArticleId IdType="pmc">PMC7482360</ArticleId><ArticleId IdType="pubmed">32888494</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard V., Stricker S., Kreuz F., Minnerop M., Gillessen-Kaesbach G., Z&#xfc;hlke C. Ataxia with oculomotor apraxia type 2: Novel mutations in six patients with juvenile age of onset and elevated serum &#x3b1;-fetoprotein. Neuropediatrics. 2008;39:347&#x2013;350. doi: 10.1055/s-0029-1214424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1214424</ArticleId><ArticleId IdType="pubmed">19569000</ArticleId></ArticleIdList></Reference><Reference><Citation>Arning L., Epplen J.T., Rahikkala E., Hendrich C., Ludolph A.C., Sperfeld A.-D. The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases. Neurogenetics. 2013;14:53&#x2013;61. doi: 10.1007/s10048-012-0347-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-012-0347-4</ArticleId><ArticleId IdType="pubmed">23129421</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;yer H., Braathen G.J., Busk &#xd8;.L., Holla &#xd8;.L., Svendsen M., Hilmarsen H.T., Strand L., Skjelbred C.F., Russell M.B. Genetic Diagnosis of Charcot-Marie-Tooth Disease in a Population by Next-Generation Sequencing. Biomed Res. Int. 2014;2014:1&#x2013;13. doi: 10.1155/2014/210401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/210401</ArticleId><ArticleId IdType="pmc">PMC4082881</ArticleId><ArticleId IdType="pubmed">25025039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghani M., Lang A.E., Zinman L., Nacmias B., Sorbi S., Bessi V., Tedde A., Tartaglia M.C., Surace E.I., Sato C., et al. Mutation analysis of patients with neurodegenerative disorders using NeuroX array. Neurobiol. Aging. 2015;36:545.e9&#x2013;545.e14. doi: 10.1016/j.neurobiolaging.2014.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.038</ArticleId><ArticleId IdType="pmc">PMC4268030</ArticleId><ArticleId IdType="pubmed">25174650</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimella C., Arnoldi A., Crippa F., Mostacciuolo M.L., Boaretto F., Sironi M., D&#x2019;Angelo M.G., Manzoni S., Piccinini L., Turconi A.C., et al. Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum. J. Med. Genet. 2009;46:345&#x2013;351. doi: 10.1136/jmg.2008.063321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2008.063321</ArticleId><ArticleId IdType="pubmed">19196735</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V., Castellotti B., Gellera C., Pareyson D., Ciano C., Nanetti L., Salsano E., Piscosquito G., Sarto E., Eoli M., et al. Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain. 2014;137:1907&#x2013;1920. doi: 10.1093/brain/awu121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu121</ArticleId><ArticleId IdType="pubmed">24833714</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Shoai M., Fratta P., Sidle K., Orrell R., Sweeney M.G., Shatunov A., Sproviero W., Jones A., Al-Chalabi A., et al. Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:1600.e5&#x2013;1600.e8. doi: 10.1016/j.neurobiolaging.2014.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.12.017</ArticleId><ArticleId IdType="pubmed">25588603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrestian N., Dupr&#xe9; N., Gan-Or Z., Szuto A., Chen S., Venkitachalam A., Brisson J.-D., Warman-Chardon J., Ahmed S., Ashtiani S., et al. Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol. Genet. 2017;3:e122. doi: 10.1212/NXG.0000000000000122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000122</ArticleId><ArticleId IdType="pmc">PMC5141523</ArticleId><ArticleId IdType="pubmed">27957547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger S., Battke F., Sprecher A., Munz M., Synofzik M., Sch&#xf6;ls L., Gasser T., Grehl T., Prudlo J., Biskup S. Rare Variants in Neurodegeneration Associated Genes Revealed by Targeted Panel Sequencing in a German ALS Cohort. Front. Mol. Neurosci. 2016;9:92. doi: 10.3389/fnmol.2016.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00092</ArticleId><ArticleId IdType="pmc">PMC5061735</ArticleId><ArticleId IdType="pubmed">27790088</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Tiloca C., Morelli C., Doretti A., Poletti B., Maderna L., Messina S., Gentilini D., Fogh I., Ratti A., et al. PON1 is a disease modifier gene in amyotrophic lateral sclerosis: Association of the Q192R polymorphism with bulbar onset and reduced survival. Neurol. Sci. 2019;40:1469&#x2013;1473. doi: 10.1007/s10072-019-03834-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03834-2</ArticleId><ArticleId IdType="pubmed">30903418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Li S., Su L., Sheng J., Lv W., Chen G., Xu Z. Association of progranulin polymorphism rs5848 with neurodegenerative diseases: A meta-analysis. J. Neurol. 2015;262:814&#x2013;822. doi: 10.1007/s00415-014-7630-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7630-2</ArticleId><ArticleId IdType="pubmed">25578179</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone B., Conforti F.L. Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: How common are common mutations in ALS genes? Expert Rev. Mol. Diagn. 2020;20:703&#x2013;714. doi: 10.1080/14737159.2020.1779060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2020.1779060</ArticleId><ArticleId IdType="pubmed">32497448</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-De-Souza D., Guest P.C., Mann D.M., Roeber S., Rahmoune H., Bauder C., Kretzschmar H., Volk B., Baborie A., Bahn S. Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration. J. Proteome Res. 2012;11:2533&#x2013;2543. doi: 10.1021/pr2012279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr2012279</ArticleId><ArticleId IdType="pubmed">22360420</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R., Eriksen J.L., Baker M., Robinson T., Ahmed Z., Lincoln S.J., Finch N., Rutherford N.J., Crook R.J., Josephs K.A., et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 2008;17:3631&#x2013;3642. doi: 10.1093/hmg/ddn257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn257</ArticleId><ArticleId IdType="pmc">PMC2581433</ArticleId><ArticleId IdType="pubmed">18723524</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Baas F., Iyer A., ten Asbroek A.L.M.A., Morello G., Cavallaro S. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol. Dis. 2015;74:359&#x2013;376. doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.Y., Syu J.S., Han T.Y., Cheng H.L., Lu F.I., Wang C.Y. Cell Cycle-Dependent Localization of Dynactin Subunit p150glued at Centrosome. J. Cell. Biochem. 2015;116:2049&#x2013;2060. doi: 10.1002/jcb.25160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.25160</ArticleId><ArticleId IdType="pubmed">25774020</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Asca&#xf1;o J., Tokito M., Van Winkle T., Howland D.S., Holzbaur E.L.F. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron. 2002;34:715&#x2013;727. doi: 10.1016/S0896-6273(02)00696-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00696-7</ArticleId><ArticleId IdType="pubmed">12062019</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann E.P., Henden L., Fifita J.A., Zhang K.Y., Grima N., Bauer D.C., Chan Moi Fat S., Twine N.A., Pamphlett R., Kiernan M.C., et al. Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis. J. Med. Genet. 2021;58:87&#x2013;95. doi: 10.1136/jmedgenet-2020-106866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2020-106866</ArticleId><ArticleId IdType="pubmed">32409511</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard S.R., Parker M.D., Cooper-Knock J., Verber N.S., Tuddenham L., Heath P., Beauchamp N., Place E., Sollars E.S.A., Turner M.R., et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2021;92:510&#x2013;518. doi: 10.1136/jnnp-2020-325014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325014</ArticleId><ArticleId IdType="pmc">PMC8053339</ArticleId><ArticleId IdType="pubmed">33589474</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Abati E., Bresolin N., Comi G., Corti S. Silence superoxide dismutase 1 (SOD1): A promising therapeutic target for amyotrophic lateral sclerosis (ALS) Expert Opin. Ther. Targets. 2020;24:295&#x2013;310. doi: 10.1080/14728222.2020.1738390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2020.1738390</ArticleId><ArticleId IdType="pubmed">32125907</ArticleId></ArticleIdList></Reference><Reference><Citation>Amado D.A., Davidson B.L. Gene therapy for ALS: A review. Mol. Ther. 2021 doi: 10.1016/j.ymthe.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8636154</ArticleId><ArticleId IdType="pubmed">33839324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>